CORRESP Filing
PURPLE BIOTECH LTD.
Date: Aug. 29, 2025 · CIK: 0001614744 · Accession: 0001213900-25-082615
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-289927
Letter
Re: Purple Biotech Ltd.
August 29, 2025
VIA FACSIMILE AND EDGAR
U.S. Securities and Exchange Commission
Division of Corporate Finance
Washington, DC 20549
Registration Statement on Form F-1 (Registration No. 333-289927) -
Concurrence in Acceleration Request
Ladies and Gentlemen:
H.C. Wainwright & Co., LLC (" Wainwright "), solely acting as placement agent on a best-efforts basis in an offering pursuant to the registration statement on Form F-1 (333-289927) (the " Registration Statement "), hereby concurs in the request by Purple Biotech Ltd. that the effective date of the above-referenced registration statement be accelerated to 9:00 A.M. Eastern Time on Wednesday, September 3, 2025, or as soon as practicable thereafter, pursuant to Rule 461 under the Securities Act. Wainwright affirms that it is aware of its obligations under the Securities Act as they pertain to the best efforts offering pursuant to the Registration Statement.
Very truly yours,
H.C. WAINWRIGHT & CO., LLC
Show Raw Text
CORRESP
1
filename1.htm
August 29, 2025
VIA FACSIMILE AND EDGAR
U.S. Securities and Exchange Commission
Division of Corporate Finance
Washington, DC 20549
Re: Purple Biotech Ltd.
Registration Statement on Form F-1
(Registration No. 333-289927) -
Concurrence in Acceleration Request
Ladies and Gentlemen:
H.C. Wainwright & Co.,
LLC (" Wainwright "), solely acting as placement agent on a best-efforts basis in an offering pursuant to the registration
statement on Form F-1 (333-289927) (the " Registration Statement "), hereby concurs in the request by Purple Biotech
Ltd. that the effective date of the above-referenced registration statement be accelerated to 9:00 A.M. Eastern Time on Wednesday, September
3, 2025, or as soon as practicable thereafter, pursuant to Rule 461 under the Securities Act. Wainwright affirms that it is aware of its
obligations under the Securities Act as they pertain to the best efforts offering pursuant to the Registration Statement.
Very truly yours,
H.C. WAINWRIGHT & CO., LLC
By:
/s/ Edward D. Silvera
Name:
Edward D. Silvera
Title:
Chief Operating Officer
430 Park Avenue | New York, NY 10022 | 212.356.0500
| www.hcwco.com
Member: FINRA/SIPC